Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9826993rdf:typepubmed:Citationlld:pubmed
pubmed-article:9826993lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C0001675lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C1318464lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C0006055lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C1533685lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C0026838lld:lifeskim
pubmed-article:9826993lifeskim:mentionsumls-concept:C0205485lld:lifeskim
pubmed-article:9826993pubmed:dateCreated1998-12-4lld:pubmed
pubmed-article:9826993pubmed:abstractTextPhysical and occupational therapists play important roles in the evaluation and management of patients receiving botulinum toxin injections for spasticity. Baseline evaluation includes areas beyond the muscles being injected, since local spasticity reduction may lead to more widespread functional changes. Because the evaluation itself influences tone, a consistent order of muscle evaluation is recommended. The range of preinjection assessments includes evaluation of tone, mobility, strength, balance, endurance, assistive devices, and others. After injection, therapeutic interventions have multiple aims, including strengthening and facilitation, increasing range of motion, retraining of ambulation and gait, improving the fit and tolerance of orthoses, and improved functioning in ADLs.lld:pubmed
pubmed-article:9826993pubmed:languageenglld:pubmed
pubmed-article:9826993pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9826993pubmed:citationSubsetIMlld:pubmed
pubmed-article:9826993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9826993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9826993pubmed:statusMEDLINElld:pubmed
pubmed-article:9826993pubmed:authorpubmed-author:AlbanyKKlld:pubmed
pubmed-article:9826993pubmed:volume6lld:pubmed
pubmed-article:9826993pubmed:ownerNLMlld:pubmed
pubmed-article:9826993pubmed:authorsCompleteYlld:pubmed
pubmed-article:9826993pubmed:paginationS221-31lld:pubmed
pubmed-article:9826993pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:meshHeadingpubmed-meshheading:9826993-...lld:pubmed
pubmed-article:9826993pubmed:year1997lld:pubmed
pubmed-article:9826993pubmed:articleTitlePhysical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.lld:pubmed
pubmed-article:9826993pubmed:affiliationWorldwide Education and Awareness for Movement Disorders, Mount Sinai Medical Center, New York, NY 10029, USA.lld:pubmed
pubmed-article:9826993pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9826993pubmed:publicationTypeReviewlld:pubmed